The Muscarinic Acetylcholine Receptor Agonist BuTAC Mediates Antipsychotic-Like Effects via the M4 Subtype

Por Watt, Marla L, Rorick-Kehn, Linda, Shaw, David B, Knitowski, Karen M, Quets, Anne T, Chesterfield, Amy K, McKinzie, David L, Felder, Christian C
Publicado em 2013

PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

Por Zheng, Bin, Liao, Zhixiang, Locascio, Joseph J., Lesniak, Kristen A., Roderick, Sarah S., Watt, Marla L., Eklund, Aron C., Zhang-James, Yanli, Kim, Peter D., Hauser, Michael A., Grünblatt, Edna, Moran, Linda B., Mandel, Silvia A., Riederer, Peter, Miller, Renee M., Federoff, Howard J., Wüllner, Ullrich, Papapetropoulos, Spyridon, Youdim, Moussa B., Cantuti-Castelvetri, Ippolita, Young, Anne B., Vance, Jeffery M., Davis, Richard L., Hedreen, John C., Adler, Charles H., Beach, Thomas G., Graeber, Manuel B., Middleton, Frank A., Rochet, Jean-Christophe, Scherzer, Clemens R.
Publicado em 2010